Spire Healthcare Group Plc

Dimensional Fund Advisors Ltd. disclosed a 2.99% interest in Spire Healthcare Group PLC, holding 12,037,853 ordinary shares as of 27 July 2026. The disclosure, made under Rule 8.3 of the Takeover Code, includes a purchase of 278 shares at 2.3150 GBP per share and a transfer out of 9,060 shares. Dimensional noted that it does not have discretion over voting decisions for 56,192 of the reported shares. No cash-settled or stock-settled derivative positions were disclosed.

Dimensional Fund Advisors Ltd. disclosed a 2.99% interest in Spire Healthcare Group PLC, holding 12,041,785 ordinary shares as of 9 July 2026. The disclosure, made under Rule 8.3 of the Takeover Code, included a purchase of 8,247 shares at 2.1460 GBP per share and a transfer in of 526 shares. Dimensional stated it does not have discretion over voting decisions for 56,192 of the reported shares.

Dimensional Fund Advisors Ltd. disclosed a 2.97% interest in Spire Healthcare Group PLC, holding 11,975,371 ordinary shares as of 26 June 2026. The disclosure was made under Rule 8.3 of the Takeover Code. Dimensional also reported a sale of 760 shares at 2.1700 GBP per share on the same date. The firm noted that it does not have discretion over voting decisions for 56,192 of the shares included in the total.